Royal Bank of Canada’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1
| Closed | – | – | 7446 |
|
|
2023
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 7289 |
|
|
2020
Q4 | – | Sell |
-2,000
| Closed | -$5K | – | 6904 |
|
|
2020
Q3 | $5K | Buy |
+2,000
| New | +$5K | ﹤0.01% | 5666 |
|
|
2019
Q3 | – | Sell |
-125
| Closed | – | – | 6409 |
|
|
2019
Q2 | $0 | Hold |
125
| – | – | ﹤0.01% | 6228 |
|
|
2019
Q1 | $0 | Hold |
125
| – | – | ﹤0.01% | 6116 |
|
|
2018
Q4 | $0 | Hold |
125
| – | – | ﹤0.01% | 6418 |
|
|
2018
Q3 | $1K | Hold |
125
| – | – | ﹤0.01% | 6042 |
|
|
2018
Q2 | $1K | Sell |
125
-5
| -4% | -$40 | ﹤0.01% | 5862 |
|
|
2018
Q1 | $1K | Sell |
130
-205
| -61% | -$1.58K | ﹤0.01% | 5651 |
|
|
2017
Q4 | $2K | Sell |
335
-200
| -37% | -$1.19K | ﹤0.01% | 5574 |
|
|
2017
Q3 | $4K | Buy |
535
+4
| +0.8% | +$30 | ﹤0.01% | 5722 |
|
|
2017
Q2 | $5K | Buy |
531
+1
| +0.2% | +$9 | ﹤0.01% | 5320 |
|
|
2017
Q1 | $6K | Hold |
530
| – | – | ﹤0.01% | 5492 |
|
|
2016
Q4 | $7K | Hold |
530
| – | – | ﹤0.01% | 5464 |
|
|
2016
Q3 | $10K | Hold |
530
| – | – | ﹤0.01% | 5034 |
|
|
2016
Q2 | $6K | Hold |
530
| – | – | ﹤0.01% | 5199 |
|
|
2016
Q1 | $10K | Sell |
530
-3,887
| -88% | -$73.3K | ﹤0.01% | 5040 |
|
|
2015
Q4 | $118K | Buy |
4,417
+3,535
| +401% | +$94.4K | ﹤0.01% | 4142 |
|
|
2015
Q3 | $40K | Sell |
882
-101
| -10% | -$4.58K | ﹤0.01% | 4667 |
|
|
2015
Q2 | $32K | Buy |
983
+31
| +3% | +$1.01K | ﹤0.01% | 4965 |
|
|
2015
Q1 | $30K | Buy |
952
+422
| +80% | +$13.3K | ﹤0.01% | 4732 |
|
|
2014
Q4 | $20K | Buy |
530
+100
| +23% | +$3.77K | ﹤0.01% | 4827 |
|
|
2014
Q3 | $11K | Sell |
430
-10
| -2% | -$256 | ﹤0.01% | 4908 |
|
|
2014
Q2 | $13K | Sell |
440
-551
| -56% | -$16.3K | ﹤0.01% | 4830 |
|
|
2014
Q1 | $37K | Buy |
991
+581
| +142% | +$21.7K | ﹤0.01% | 4456 |
|
|
2013
Q4 | $17K | Sell |
410
-2,403
| -85% | -$99.6K | ﹤0.01% | 4690 |
|
|
2013
Q3 | $149K | Buy |
2,813
+2,023
| +256% | +$107K | ﹤0.01% | 3725 |
|
|
2013
Q2 | $42K | Buy |
+790
| New | +$42K | ﹤0.01% | 4161 |
|